Zhejiang Medicine Co., Ltd. (600216.SS) — Stock Score Summary

Zhejiang Medicine Co., Ltd. (600216.SS) has a MoatMap StockRank of 89/100 based on Quality (66/100), Value (72/100), and Momentum (39/100) factor scores. The current signal is STRONG BUY. Zhejiang Medicine is a Chinese pharmaceutical and vitamin manufacturer. It operates in highly commoditized API and vitamin markets with low pricing power, failing our CDMO high-moat criteria.

Zhejiang Medicine Co., Ltd. manufactures active pharmaceutical ingredients (APIs), human nutrition products like vitamins, and finished drug formulations. The company commands a leading global market position in synthetic Vitamin E and biotin production, benefiting from significant scale economies and advanced chemical synthesis capabilities. It operates as a vertically integrated, export-oriented pharmaceutical and nutritional ingredients giant.

Key Financial Metrics

Price$1.76
Market Cap$1.8B
P/E (TTM)15.58
P/E (Forward)10.66
Price/Book1.03
Return on Equity5.6%
Return on Invested Capital8.4%
Debt/Equity8.42
Gross Margin30.5%
Operating Margin15.1%
Revenue Growth-2.9%
Dividend Yield3.1%
Free Cash Flow$24M

Zhejiang Medicine Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Medicine Co., Ltd.’s (600216.SS) StockRank?
MoatMap’s StockRank for Zhejiang Medicine Co., Ltd. (600216.SS) is 89/100, with a Strong Buy signal. It is a composite of Quality (66), Value (72), and Momentum (39) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Medicine Co., Ltd. have an economic moat?
Zhejiang Medicine Co., Ltd. (600216.SS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Medicine Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Medicine Co., Ltd. (600216.SS) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Medicine Co., Ltd. in?
Zhejiang Medicine Co., Ltd. (600216.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600216.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock